Liliana Soroceanu Selected Research

Liliana Soroceanu Research Topics

Disease

30	Neoplasms (Cancer) 03/2024 - 01/2002
12	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 02/2007
9	Glioma (Gliomas) 11/2016 - 01/2002
6	Melanoma (Melanoma, Malignant) 01/2022 - 02/2015
6	Infections 01/2014 - 12/2007
3	Cholangiocarcinoma 03/2024 - 10/2020
3	Brain Neoplasms (Brain Tumor) 01/2023 - 05/2012
2	Neoplasm Metastasis (Metastasis) 06/2015 - 01/2002
2	Virus Diseases (Viral Diseases) 12/2013 - 02/2008
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2024
1	Genomic Instability 08/2021
1	Cutaneous Malignant Melanoma 01/2021
1	Deficiency Diseases (Deficiency Disease) 11/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Pain (Aches) 06/2015
1	Nausea 06/2015
1	Vomiting 06/2015
1	Disease Progression 05/2012
1	Inflammation (Inflammations) 11/2011

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2007
6	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 03/2006
4	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 12/2013
3	Phosphotransferases (Kinase)IBA 03/2024 - 12/2007
3	CannabidiolIBA 01/2022 - 03/2013
3	CannabinoidsIBA 01/2022 - 06/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 01/2002
3	Viral ProteinsIBA 02/2014 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2015
2	LigandsIBA 01/2023 - 12/2007
2	Mitogen-Activated Protein KinasesIBA 01/2023 - 01/2022
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 02/2007
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2020
2	Gemcitabine FDA Link 08/2021 - 10/2020
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2021 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
2	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 01/2020 - 01/2018
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2020 - 12/2007
2	IntegrinsIBA 01/2020 - 12/2007
2	Glycoproteins (Glycoprotein)IBA 02/2014 - 12/2007
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2008 - 02/2007
1	Tyrosine Kinase InhibitorsIBA 03/2024
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2024
1	PeriostinIBA 01/2023
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023
1	ChemokinesIBA 01/2023
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2023
1	sapanisertibIBA 01/2023
1	TOR Serine-Threonine KinasesIBA 01/2023
1	Circulating Tumor DNAIBA 11/2022
1	Cell-Free Nucleic AcidsIBA 11/2022
1	bromosporineIBA 01/2022
1	cobimetinibIBA 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	Alkylating AgentsIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	AcidsIBA 08/2021
1	DeoxyribonucleotidesIBA 08/2021
1	niraparibIBA 08/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	dinaciclibIBA 10/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2020
1	Complementary DNA (cDNA)IBA 01/2020
1	TalinIBA 01/2020
1	VinculinIBA 01/2020
1	PaxillinIBA 01/2020
1	Drug CombinationsIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 08/2019
1	Cyclin D1IBA 01/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017
1	CPT417IBA 11/2016
1	CamptothecinIBA 11/2016
1	NestinIBA 08/2015
1	cytomegalovirus immediate-early proteinsIBA 08/2015
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 06/2015
1	Dronabinol (THC)FDA LinkGeneric 06/2015
1	CB2 Cannabinoid ReceptorIBA 06/2015
1	fetal Alzheimer antigenIBA 02/2015
1	Small Interfering RNA (siRNA)IBA 02/2015
1	Neutralizing AntibodiesIBA 02/2014
1	matrigelIBA 02/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	NucleosidesIBA 12/2013
1	Antiviral Agents (Antivirals)IBA 12/2013
1	Cidofovir (Vistide)FDA Link 12/2013
1	Therapeutic UsesIBA 12/2013
1	Stem Cell FactorIBA 01/2013
1	GlycosyltransferasesIBA 05/2012
1	Laminin (Merosin)IBA 05/2012
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2011
1	Platelet-Derived Growth Factor alpha ReceptorIBA 09/2008

Therapy/Procedure

11	Therapeutics 01/2024 - 09/2008
2	Precision Medicine 01/2023 - 11/2022
2	Drug Therapy (Chemotherapy) 10/2020 - 06/2015
1	Immunotherapy 01/2022
1	Self Medication 01/2021
1	Radiotherapy 12/2013